Paratek Pharmaceuticals, Inc.
PRTKDelisted Sep 21, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178711
Paratek Pharmaceuticals, Inc. was delisted on Sep 21, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 66 institutions reported holding it in 13F filings for Q2 2023, worth $47.0M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Paratek Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 103 | 1 | 100 | −2 |
| Shares | 25.4M | 1.00K | 27.6M | +2.22M (+8.7%) |
| Value | $114.1M | $4.00K | $82.1M | −$32.0M (−28.0%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| J. Goldman & Co LP | 1,056,631 | $3.14M | 0.24% |
| Highbridge Capital Management LLC | 203,083 | $603.0K | 0.02% |
| Schonfeld Strategic Advisors LLC | 169,800 | $504.0K | 0.01% |
| Millennium Management LLC | 158,171 | $470.0K | 0.00% |
| Jump Financial, LLC | 22,700 | $67.0K | 0.00% |
| Occudo Quantitative Strategies LP | 20,254 | $60.0K | 0.01% |
| Kalos Management, Inc. | 14,550 | $43.0K | 0.03% |
| Amalgamated Bank | 7,975 | $24.0K | 0.00% |
| Amalgamated Financial Corp. | 7,975 | $24.0K | 0.00% |
| Prospera Financial Services Inc | 4,465 | $13.0K | 0.00% |
| Aquatic Capital Management LLC | 3,000 | $9.00K | 0.01% |
| Point72 Hong Kong Ltd | 1,651 | $5.00K | 0.00% |
Sold out (14)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Granahan Investment Management Inc | 749,740 | $3.37M |
| Trexquant Investment LP | 59,480 | $267.0K |
| Stifel Financial Corp | 43,773 | $197.0K |
| Weil Company, Inc. | 33,235 | $149.0K |
| SG Americas Securities, LLC | 19,274 | $87.0K |
| Campbell & CO Investment Adviser LLC | 17,000 | $76.0K |
| Wolverine Trading, LLC | 14,044 | $62.0K |
| State of Wyoming | 12,561 | $56.0K |
| Cutter & CO Brokerage, Inc. | 10,900 | $49.0K |
| Dynamic Technology Lab Private Ltd | 10,657 | $48.0K |
| EverSource Wealth Advisors, LLC | 573 | $3.00K |
| Lenox Wealth Advisors, LLC | 500 | $2.00K |
| Evoke Wealth, LLC | 468 | $2.00K |
| Ellevest, Inc. | 32 | $0 |
Not filed for Q1 2022 yet (1)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| NEXT Financial Group, Inc | 1,000 | $4.00K |